About Dr. Brig S Viswanath
Dr. Brig S Viswanath is a highly experienced and top Medical Oncologist in India with over two decades of dedicated service in cancer care. As a leading Medical Oncologist, he holds extensive expertise in diagnosing and treating a wide spectrum of oncological conditions, including Actinic keratosis, Cholangiocarcinoma, and various leukaemias. His proficiency extends to advanced procedures like chemotherapy, immunotherapy, targeted therapy, and bone marrow transplants. Dr. Viswanath is recognised for his patient-centric approach and commitment to delivering comprehensive cancer treatment, making him a trusted name among cancer specialists in India.
Qualifications & Credentials
- MBBS – Karnatak Medical College, Hubli, Karnatak University, Dharwad.
- MD (Gen. Med.) – Command Hospital, Airforce, Bangalore, Rajiv Gandhi University of Health Science, Bengaluru.
- DM (Med. Onco.) – Cancer Institute (WIA), Adyar, Chennai – The Tamilnadu MGR Medical University, Chennai.
- Classified specialist in Medicine and Medical Oncology.
Areas of Expertise
- Cholangiocarcinoma
- Hairy cell leukaemia
- Ovarian cysts
- Acute Lymphoblastic Leukaemia
- Renal Cell Carcinoma
- Hodgkin Lymphoma
- Langerhans Cell Histiocytosis
- Malignant Melanoma
- Gastric Cancer
- Medical Oncology
- Haemato-Oncology
- Chemotherapy Administration
- Immunotherapy
- Targeted Therapy
- Bone Marrow Transplants
- Biopsies for cancer diagnosis
Professional Experience
- Current Affiliations:
- Dr Rela's Institute and Medical Centre, Chennai (Dec 2024 - Present)
- Past Affiliations:
- Madras Cancer Care Foundation, Chennai (Apr 2021 - Feb 2025)
- Command Hospital (WC) (May 2006 - May 2009)
- Command Hospital (EC) (Jun 2009 – Jun 2011)
- Army Hospital (R&R) (Jun 2012 - Jun 2018)
- Command Hospital (CC), Lucknow (Jun 2018 - Jul 2020)
- Military Hospital, Chennai (Jul 2020 – Apr 2021)
- Army Medical Services (Apr 1991 - Apr 2021)
- Professor of Medicine and Medical Oncology
- Examiner for DNB Medical Oncology.
- Head of Department (HOD) and conducted MCI inspections.
- Over 20 years of extensive experience in treating cancer patients.
- Served as Senior Advisor and Consultant in Medical Oncology in the Indian Army.
Research & Publications
- Two cases of refractory rheumatoid arthritis treated with Rituximab, Indian Journal of Rheumatology, Vol2, Issue 3,S27:sept 2007.
- Clinicopathological profile of bronchogenic carcinoma in a tertiary care hospital in eastern part of India, Clinical Cancer Investig J 2014;3:220-4.
- T- lymphoblastic lymphoma in an undiagnosed rheumatoid arthritis- A rare occurrence Indian Journal of Rheumatology,Vol. 10, Issue 1,p48-50, 2015.
- Changing paradigm in treatment of lung cancer, J Cancer Metasta Treat 2016;2:214-9.
- A case of metastatic insulinoma: Management and review of literature, OGH Reports, 2016; 5(2):79-81.
- Management of HER2-positive breast cancer: A review, J NTR Univ Health Sci 2016;5:87-92.
- Paraneoplastic limbic encephalitis forgotten etiology of altered sensorium, Int J Adv Med 2016;3:771-3.
- A Clinico demographic Study of Receptor status in Carcinoma Breast, J Carcinog 2016, 15:2(7 April 2016) (ACOS Abstracts):S162.
- Primary CNS Lymphoma in Immunocompetent Patient – Case Series, J Carcinog 2016, 15:2, 7 April 2016) (ACOS Abstracts):S215.
- Adenoid Cystic Carcinoma of Lung: A oncological rarity treated with definitive chemoradiation, Int JCancer Ther Oncol.2016; 4(3):4315.
- Incidence of K-RAS mutation in metastatic colorectal carcinoma and further to find any associated correlation between K-RAS mutation and various demographic and clinical factors. A Hospital based study(#652).
- To compare and determine the diagnostic accuracy of [18F]- fluorodeoxyglucose positron emission tomography scan in predicting pathological response in operated carcinoma esophagus patients after initial neoadjuvant chemoradiation and neoadjuvant chemotherapy, World J Nucl Med2018;17:79-85.
Patient Success Stories & Testimonials
- "Dr. Viswanath’s compassionate approach and clear explanations made my chemotherapy journey much less daunting. I felt genuinely cared for throughout my treatment." – Ramesh K.
- "Choosing Dr. Brig S Viswanath for my treatment was the best decision. His expertise in Medical Oncology is truly commendable, and his team provided exceptional support." – Priya S.
- "I am incredibly grateful to Dr. Viswanath for his unwavering dedication. His innovative treatment plan for my Renal Cell Carcinoma gave me a new lease on life." – Anjali M.
Treatment Approach & Philosophy
Treatment Costs
| Treatment Type | Cost in INR (approx.) | Cost in USD (approx.) |
| Chemotherapy Session | ₹15,000 - ₹1,00,000 | $180 - $1,200 |
| Immunotherapy Session | ₹1,50,000 - ₹4,00,000 | $1,800 - $4,800 |
| Targeted Therapy (per cycle) | ₹50,000 - ₹3,00,000 | $600 - $3,600 |
| Bone Marrow Transplant (Autologous) | ₹10,00,000 - ₹25,00,000 | $12,000 - $30,000 |
| Bone Marrow Transplant (Allogeneic) | ₹25,00,000 - ₹50,00,000 | $30,000 - $60,000 |









